KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Net Cash Flow (2016 - 2026)

Amgen has reported Net Cash Flow over the past 18 years, most recently at $2.9 billion for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 191.97% year-over-year to $2.9 billion; the TTM value through Mar 2026 reached $3.2 billion, up 459.47%, while the annual FY2025 figure was -$2.8 billion, 376.38% down from the prior year.
  • Net Cash Flow for Q1 2026 was $2.9 billion at Amgen, up from -$316.0 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $23.9 billion in Q1 2023 and troughed at -$23.8 billion in Q4 2023.
  • A 5-year average of $238.2 million and a median of -$316.0 million in 2025 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 1737.99% in 2023 and fell as far as 1170.53% in 2023.
  • Year by year, Net Cash Flow stood at -$1.9 billion in 2022, then tumbled by 1170.53% to -$23.8 billion in 2023, then skyrocketed by 112.45% to $3.0 billion in 2024, then tumbled by 110.67% to -$316.0 million in 2025, then skyrocketed by 1020.57% to $2.9 billion in 2026.
  • Business Quant data shows Net Cash Flow for AMGN at $2.9 billion in Q1 2026, -$316.0 million in Q4 2025, and $1.4 billion in Q3 2025.